Overview

• Animal and Pandemic Influenza: A Framework for Sustaining Momentum, United Nations & The World Bank, 2010
  

Preparedness and Response

• Communication in a Pandemic: Lessons from the H5N1 and H1N1 Experiences, Academy for Educational Development, 2011
  
• Pandemic Influenza Preparedness Framwork for the Sharing of Influenza Viruses and Access to Vaccines and other Benefits, WHO, 2011
  
• Pandemic Response Lessons from Influenza H1N1 2009 in Asia, Respirology, 2011
  
• Report of the Review Committee on the Functioning of the International Health Regulations in relation to Pandemic (H1N1), WHO, 2011
  
• Pandemic Influenza Preparedness and Response, WHO, 2010
  

Avian Influenza Vaccines - Research and Development

• Stockpiled Avian Flu Vaccine Could Protect Against Potential Pandemic, ScienceDaily, 2011
  
• 2009 H1N1 Influenza Vaccine Clinical Trials, NIAID, 2010
  
• Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials, The Lancet, 2010
  
• Unlicensed pandemic influenza A H1N1 vaccines, The Lancet, 2010
  
• Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic, Nature, 2009
  
• Response to a Monovalent 2009 Influenza A (H1N1) Vaccine, The New England Journal of Medicine, 2009
  
• Trial of 2009 Influenza A (H1N1) Monovalent MF59-Advuvanted Vaccine, The New England Journal of Medicine, 2009
  
• R&D for Avian/Pandemic Influenza Vaccines by IFPMA Influenza Vaccine Supply International Task Force Members, January 24,International Federation of Pharmaceutical Manufacturers (IFPMA), 2006
  
• Influenza Vaccine Research & Development, IFPMA, 2006.
  

Pre- and Post-Pandemic - Vaccine Supply and Dissemination

• Pandemic influenza preparedness: options for sustainable financing of benefit sharing
  
• Final Pandemic (H1N1) 2009 vaccine deployment update, WHO, 2010
  
• Influenza Vaccine Manufacturers, WHO, 2009
  
• WHO Initiative for Vaccine Research (IVR), Request for Applications: Establishment of an International Technology Platform for Influenza Vaccines.
  
• WHO IVR, Global Pandemic Influenza Action Plan to Increase Vaccine Supply, WHO, 2006.
  

Regulatory Issues

• WHO Meeting on Regulatory Preparedness for Human Pandemic Influenza Vaccines, June 14-15, 2007, Geneva.
  
• Center for Biologics and Evaluation Research (CBER), "Guidance for Industry Clinical Data Needed to Support the Licensure of Pandemic Influenza Vaccines," U.S. FDA, May 2007.